EU
OMass Therapeutics
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics for rare diseases and immunological conditions using its OdyssION platform.
omass.com
1
aktywne oferty
Zobacz wszystkie oferty firmy
Hybrydowo 1
O firmie
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics. Its work focuses on rare diseases and immunological conditions, with programmes aimed at targets such as membrane proteins, intracellular complexes, solute carriers and GPCRs. The company describes its OdyssION platform as combining novel biochemistry, native mass spectrometry and custom chemistry.
Wa偶ne dla kandydat贸w
- Biotechnology company developing small-molecule therapeutics.
- Focuses on rare diseases and immunological conditions.
- Uses the OdyssION technology platform for drug discovery.
- Sektor gospodarki
- Biotechnology
- Profil handlowy
- Drug discovery and development of small-molecule therapeutics
- Siedziba
- Oxford
Aktualne oferty
1
aktywne oferty
- G艂贸wne miasta
- Oxford (1)
- Tryb pracy
- Hybrydowo (1)
- Forma zatrudnienia
- Pe艂ny etat (1)